180 Life Sciences Corp. (NasdaqCM:ATNF) has hired A.G.P./Alliance Global Partners as financial adviser to explore and evaluate strategic alternatives to enhance shareholder value. Potential strategic alternatives that may be explored or evaluated by the biotechnology company include an acquisition, merger, reverse merger, other business combination, sale of assets and licensing.

The company doesn't intend to discuss or disclose further developments during this process unless and until its board has approved a specific action or otherwise determined that further disclosure is appropriate. 180 Life Sciences said there is no assurance that the strategic review process will result in the approval or completion of any specific transaction or outcome.